Page 134 - 2026 SMOG
P. 134

KETAMINE (KETALAR)
                              Class/Mechanism of Action
         •  Antidepressant; General Anesthetic
           Dissociative anesthetic; produces a cataleptic-like state acting directly on the cortex and limbic system.
              ˚  Onset of action—IV: 30–60sec; Duration: dose dependent averaging 10–20min
                                    Indications
         •  Labeled Indications
             Induction and maintenance of general anesthesia
         •     ˚ Off-Label Indications
             Analgesia and sedation
              ˚   ˚ Preferred general anesthetic/sedative (pre-hospital) for head injury patients (does not raise ICP)
                                  Contraindications
         •  Hypersensitivity to ketamine or any component of the formulation
         •  Conditions that cannot tolerate sustained increases in blood pressure (non-traumatic intracerebral
           hemorrhage, hypertension associated with acute coronary syndrome; NOT contraindicated in TBI)
         •  Children <3 months in age
                            Adverse Reactions/Precautions
         •  Rapid IV administration may cause hypotension, apnea, or laryngospasm. Large doses (>1mg/kg) may
           cause hypotension and respiratory depression.
         •  Use with caution in patients with cardiovascular disease. Continuously monitor cardiac function.
         •  Dosing between 0.5–0.9mg/kg IV (and equivalent IM dose) can give patients the feeling of unreality,
           leading to agitation, and should be avoided.
         •  If the patient experiences Ketamine Induced Agitation (Emergence Phenomena), give Midazolam
         •  2–5mg IV one time for adults and 0.05mg/kg for children who are not hypotensive or in danger of being
           hypotensive
         •  Pregnancy: Low doses of ketamine may be used, but other agents are preferred.
         •  Lactation: Use caution
                                Dose/Administration
                                                    PEDIATRIC
                      ADULT
                                              (Always reference Broselow Tape)
         LOW DOSE                        Analgesia/Sedation
         Analgesia                       •  IV
         •  IV/IO Push over 1min             0.1–0.3mg/kg, slow IV push or infusion over
             0.1–0.3mg/kg, q10–30min prn      ˚ 10–15min
         •     ˚ IM/IN                   •  IN (children >6 years old)
              ˚  0.5–1.0mg/kg, q10–30min prn    ˚  0.5–1mg/kg, may repeat 0.25mg/kg in 10min
         HIGH DOSE                       Induction of anesthesia
         RSI/Induction of Anesthesia; Combative Patients  •  IV 1–2mg/kg
                                              ˚
         •  IV (SLOW)                    Maintenance of anesthesia
             1–2mg/kg
         •     ˚ IM                      •  IV Continuous Infusion (infants ≥5 months,
                                           children, and adolescents)
              ˚  4–5mg/kg                    0.5–2mg/kg IV, then 5–20mcg/kg/min IV
         Maintenance of anesthesia            ˚ infusion, starting at the lowest dose and
         •  IV                               titrating upward prn
             0.5–2mg/kg q10–20min        Note: Avoid sub-dissociative doses to prevent an
         •     ˚ IV Continuous Infusion  emergence phenomenon
             0.5–2mg/kg bolus, then 1–3mg/kg/hr.
              ˚ Titrate levels by 0.25mg/kg/hr as needed to   Note: If the patient experiences Ketamine Induced
             achieve appropriate sedation (See infusion   Agitation (Emergence Phenomena), give Midazolam
                                         2–5mg IV one time for adults and 0.05mg/kg for
             chart next page)
                                         children who are not hypotensive or in danger of
                                         being hypotensive
        126  •   MEDICATIONS
   129   130   131   132   133   134   135   136   137   138   139